Press conference by Joaquín Almunia, on the fine imposed by the EC to Servier and five generic companies for curbing entry of cheaper versions of cardiovascular medicine
On 9 July 2014, Joaquín Almunia, Vice-President of the EC in charge of Competition, gave a press conference on the fine imposed by the EC to Servier and five generic companies for curbing entry of cheaper versions of cardiovascular medicine. The Commission imposed fines totalling €427.7 million on the French pharmaceutical company Servier and five producers of generic medicines – namely, Niche/Unichem, Matrix (part of Mylan), Teva, Krka and Lupin – for concluding a series of deals of deals all aimed at protecting Servier's bestselling blood pressure medicine, perindopril, from price competition by generics in the EU.
Type: Complete press conference Reference: I-091136 Date: 09/07/2014 Duration: 41:25 DG:Directorate-General for CommunicationLocation:Brussels - EC/Berlaymont Thesaurus:Competition,Competitiveness,Fine,Generic medicine,Pharmaceutical industry Personalities:Joaquín Almunia Aman
EC - Audiovisual Service